Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects

E-ISSN： 1875-533x|24|33|3649-3665

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.24, Iss.33, 2017-10, pp. : 3649-3665

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leukocytes and neurogenic inflammation

By Grant Andrew

Inflammopharmacology, Vol. 9, Iss. 4, 2001-08 ,pp. : 403-420

VSP

Access to resources Recommend Favorite

Neurogenic Inflammation and Asthma

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 2, 2007-06 ,pp. : 127-132

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacological Targets for the Inhibition of Neurogenic Inflammation

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 2, Iss. 2, 2003-06 ,pp. : 191-218

Bentham Science Publishers

Access to resources Recommend Favorite

Regulatory aspects of integration of pharmacogenetics into drug development

By R S.R.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 67-69

Adis International

Access to resources Recommend Favorite

The Airway Neurogenic Inflammation: Clinical and Pharmacological Implications

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 3, 2009-07 ,pp. : 176-181

Bentham Science Publishers

Access to resources Recommend Favorite